Asterias Biotherapeutics, Inc. Common Series A (AST)

$0.94 0.00 (-0.53%)

in Biotech

Asterias Biotherapeutics, Inc. Common Series A (AST)

$0.94 USD

0.00 (-0.53%)

Updated Mar 7 8:00pm

Add AST to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

Trade Grade Buy & Hold Grade Peer Grade Industry Rank

Industry Rank:

Ranked of 322 in Biotech

See all “A” rated Strong Buy stocks

AST Daily Price Range

AST 52-Week Price Range

Learn More About POWR Ratings

AST News Stream

Event/Time	News Detail	Start	End	Change
Loading, please wait...

View All AST News

Asterias Biotherapeutics, Inc. Common Series A (AST) Company Bio

Asterias Biotherapeutics, Inc., a biotechnology company, focuses on the emerging field of regenerative medicines. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. The company was founded in 2012 and is based in Fremont, California.

AST Stock Chart More Charts

AST Price/Volume Stats

Current price	$0.94
Prev. close	$0.95
Day low	$0.90
Day high	$0.95
50-day MA	$0.82
200-day MA	$1.25
52-week high	$2.05
52-week low	$0.51
Volume	99,200
Avg. volume	136,653
Dividend yield	N/A
Market Cap	52.32M

AST Social Stream

View Full AST Social Stream

AST Returns

1-mo	N/A
3-mo	N/A
6-mo	51.61%
1-year	-47.78%
3-year	-68.35%
5-year	N/A

YTD	51.61%
2018	-72.44%
2017	-51.09%
2016	17.05%
2015	21.30%
2014	N/A

Asterias Biotherapeutics, Inc. Common Series A (AST)

Asterias Biotherapeutics, Inc. Common Series A (AST)

Overall POWR Rating

POWR Components:

Industry Rank:

See all “A” rated Strong Buy stocks

AST News Stream

Asterias Biotherapeutics, Inc. Common Series A (AST) Company Bio

AST Stock Chart More Charts

AST Price/Volume Stats

AST Social Stream

AST Returns

Top Stories View All

8 Extreme Value Stocks

What caused Blue Apron Holdings (APRN) stock to tank today?

Canopy Growth (CGC) reminds shareholders to vote in favor of a potential acquisition

After recent weakness, is oil services company Schlumberger (SLB) a Buy?

Disney (DIS) is on track to set a box office record this year, is their stock a Buy?